MDD US Operations, LLC
$1.8M 11,285 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
XVIVO Perfusion Inc.
XVIVO Perfusion Inc. reported $1,825,487.97 across General Payments, Research, and Ownership to 141 physicians and teaching hospitals across 188 transactions.
- $1.8M Top quartile payer
- All-tracks total
- 188 Above-median volume
- Transactions
- 141 Above-median reach
- Recipients
- +$21.6K
- General Payments vs PY2023
XVIVO Perfusion Inc. reported $1,825,487.97 across all CMS Open Payments tracks (General + Research + Ownership) to 141 physicians and teaching hospitals in Program Year 2024 - ranking #472 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $51,761.44, averaging $12.9K per recipient.
How XVIVO Perfusion Inc.'s $1.8M all-tracks total breaks down
XVIVO Perfusion Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
25/100
Total payments
F
27/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer xvivo-perfusion-inc XVIVO Perfusion Inc.
$1.8M · #472/1,925 · 0.0% industry · PY2024
- TOT $1.8M
- RANK #472
- SHARE 0.0%
- TXN 188
- RCP 141
- CAT 4
- GEN $51.8K
- ΔGEN +$21.6K
- TOP1 12.6%
- PY 2024
Volume peers
Nearest volume peer: MDD US Operations, LLC ($1.8M)
XVIVO Perfusion Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
XVIVO Perfusion Inc.'s CMS-reported General Payments increased by $21.6K (+71.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: XVIVO PERFUSION INC.PY2023: XVIVO PERFUSION INC.PY2024: XVIVO Perfusion Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $30,177.37
- PY2024
- $51,761.44
What the Data Shows for XVIVO Perfusion Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For XVIVO Perfusion Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 4 general-payment categories charted below, "Food and Beverage" is the largest at $23.1K across 115 transactions, 44.7% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
XVIVO Perfusion Inc. made 4 types of general payments. "Food and Beverage" is the largest category at $23.1K, 44.7% of General Payments.
XVIVO Perfusion Inc. reports 4 general-payment categories - the top three are Food and Beverage (44.7%), Compensation for Services Other Than Consulting (29.0%), and Travel and Lodging (20.5%). The remaining 1 category make up 5.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How XVIVO Perfusion Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $23.1K | 115 | 44.7% |
| Compensation for Services Other Than Consulting | $15.0K | 7 | 29.0% |
| Travel and Lodging | $10.6K | 18 | 20.5% |
| Honoraria | $3.0K | 1 | 5.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $17,254.90 (33.3%) of $51,761.44 in this company's General Payments records across 100 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for XVIVO Perfusion Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Toshihiro Okamoto
$6,504.90 across 4 reported transactions
- 2
James Kirklin
$3,000.00 across 1 reported transactions
- 3
Ezequiel Molina
$3,000.00 across 1 reported transactions
- 4
David Mcgiffin
$2,500.00 across 1 reported transactions
- 5
Farooq Sheikh
$2,250.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
XVIVO Perfusion Inc. ranks #472 of 1,925 by total payments (top 25% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,391 of 1,838 by HHI (bottom 24% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Medela LLC : $63.1K total payments, HHI 384
- Ovesco Endoscopy USA, Inc. : $61.0K total payments, HHI 384
- Augmedics Inc. : $233.7K total payments, HHI 383
- Daiichi Sankyo Inc. : $6.9M total payments, HHI 382
- Biocomposites Inc : $138.8K total payments, HHI 381
- Dental Health Products, Inc. : $7.5K total payments, HHI 380
- XVIVO Perfusion Inc. (this company) : $51.8K total payments, HHI 377
- Carl Zeiss Meditec, Inc. : $938.6K total payments, HHI 376
- CDC Medical LLC : $22.6K total payments, HHI 376
- Gynesonics, Inc. : $1.1M total payments, HHI 375
- BioCryst US Sales Co., LLC : $658.2K total payments, HHI 374
- Janssen Research & Development, LLC : $4.7M total payments, HHI 372
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as XVIVO Perfusion Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about XVIVO Perfusion Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with XVIVO Perfusion Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Idorsia Pharmaceuticals US Inc
$1.8M 20,929 recipients
Compare payment profiles
Guerbet LLC
$1.8M 368 recipients
Compare payment profiles
Merck Healthcare KGaA
$1.8M 36 recipients
Compare payment profiles
Ferring Pharmaceuticals AS
$1.8M 83 recipients
Compare payment profiles
A-dec, Inc.
$1.8M 7,139 recipients
Compare payment profiles
Put this to use
XVIVO Perfusion Inc. ranks #472 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See where XVIVO Perfusion Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just XVIVO Perfusion Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.